AI-POWERED ANALYSIS: INTERPRETABLE ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTING HEART FAILURE SEVERITY AFTER ACUTE MYOCARDIAL INFARCTION
Interpretable artificial intelligence model for predicting heart failure severity after acute myocardial infarction
This study develops an interpretable AI model to predict heart failure (HF) severity after acute myocardial infarction (AMI) using multidimensional clinical data. Leveraging deep learning (TabNet, MLP) and machine learning (Random Forest, XGBoost) models, with SHAP for interpretability, the model achieves high accuracy. TabNet demonstrates superior performance (AUROC 0.827 for four-class, 0.831 for binary KILLIP classification). Key factors like GRACE score, NT-pro BNP, and TIMI score are strongly correlated with KILLIP classification. The model provides early, personalized HF risk prediction, supporting timely clinical interventions and improving patient outcomes.
Executive Impact: Quantifying AI's Value
Deploying this AI model can significantly reduce mortality and morbidity associated with post-AMI heart failure, leading to improved patient outcomes and substantial healthcare system efficiencies.
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Enterprise Process Flow
| Feature | TabNet | MLP | Random Forest | XGBoost |
|---|---|---|---|---|
| AUROC |
|
|
|
|
| AUPRC |
|
|
|
|
| F1 Score |
|
|
|
|
Interpretable Risk Factors for Heart Failure Severity
The SHAP analysis revealed crucial factors influencing HF risk after AMI. Patients with higher GRACE risk score, TIMI risk score, age, and elevated NT-pro BNP, creatinine, hs-CRP, and IL-6 showed an increased risk. Conversely, higher LVEF and CCR were linked to a decreased risk. This aligns with established clinical understanding and empowers clinicians to identify high-risk patients early.
Seamless Clinical Integration via Web Platform
To facilitate practical clinical application, the developed KILLIP prediction model has been integrated into a user-friendly web platform: https://prediction-killip-gby.streamlit.app/. This platform enables clinicians to input patient data and automatically receive Killip classification predictions, streamlining early risk assessment and guiding personalized treatment strategies.
Quantify Your Potential ROI
See how an AI-powered solution for cardiovascular risk prediction can translate into tangible savings and reclaimed productivity for your enterprise.
Phased AI Integration for Cardiovascular Care
Our recommended roadmap for integrating this predictive AI model into clinical practice, ensuring a smooth transition and maximizing impact.
Phase 1: Pilot Deployment & Validation
Initial deployment in a controlled clinical setting, validating model predictions against physician assessments and refining the web platform for user experience.
Phase 2: Staff Training & Protocol Integration
Comprehensive training for medical staff on using the AI tool, integrating its insights into existing clinical protocols for AMI patient management.
Phase 3: Scaled Rollout & Continuous Monitoring
Expand deployment across multiple departments or hospitals, establishing continuous monitoring for model performance and patient outcomes, and gathering feedback for iterative improvements.
Accelerate Your AI Strategy
Ready to transform your cardiovascular care with cutting-edge AI? Book a session with our experts to discuss how this interpretable model can be tailored for your enterprise.